The most studied DPP4i

Composition : Teneligliptin 20mg

Form : Tablets / Pack : 10’s / Type : ALU-ALU

Description : Unique structure (*Anchor lock domain* - S2 extensive binding). High selectivity and tight binding (5 fold) for DPPi4 Longer half life (t1/2: ~24 hours) Less chances of food-drug and drug-drug interactions, Proven efficacy as mono as well as combination therapy. Effective glycemic control. Duel route of excretion so effective in patients of renal impairment.

View more products with following salts